| Q24301956 | Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion |
| Q37601916 | CA 125 concentration in portal blood as a predictor of resectability in pancreatic tumor |
| Q24170226 | CA125 expression in spontaneous ovarian adenocarcinomas from laying hens |
| Q33859857 | CA125 in ovarian cancer |
| Q43485791 | Cancer antigen 125 levels and increased risk of new-onset atrial fibrillation. |
| Q48129798 | Cancer antigen-125 and risk of atrial fibrillation: a systematic review and meta-analysis |
| Q35954702 | Carbohydrate antigen 125: an emerging prognostic risk factor in acute heart failure? |
| Q39819484 | Characterization of de novo synthesized proteins released from human colorectal tumour explants |
| Q37326840 | Clinical potential of mucins in diagnosis, prognosis, and therapy of ovarian cancer. |
| Q27015008 | Deciphering the molecular nature of ovarian cancer biomarker CA125 |
| Q36516283 | Determination of CA-125 levels in the serum, cervical and vaginal secretions, and endometrium in Chinese women with precancerous disease or endometrial cancer |
| Q37324626 | Development of a CA125-mesothelin cell adhesion assay as a screening tool for biologics discovery |
| Q44641810 | Influence of surgery and postoperative therapy and tumor characteristics on patient prognosis in advanced ovarian carcinomas |
| Q33713506 | MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress |
| Q52430876 | MUC16 overexpression induced by gene mutations promotes lung cancer cell growth and invasion. |
| Q44332743 | Metaplastic potential of p53 down-regulation in ovarian surface epithelial cells affected by ovulation |
| Q34403506 | Methods for identification of CA125 from ovarian cancer ascites by high resolution mass spectrometry |
| Q81301278 | Normalization of cancer antigen 125 after mitral valve replacement in a patient with congestive heart failure due to mitral valve endocarditis |
| Q34069612 | Pathobiological implications of MUC16 expression in pancreatic cancer |
| Q37722784 | Prognostic value of increased carbohydrate antigen in patients with heart failure. |
| Q34007762 | Successful eradication of established peritoneal ovarian tumors in SCID-Beige mice following adoptive transfer of T cells genetically targeted to the MUC16 antigen. |
| Q77565983 | [CA-125 antigen as peritoneal tuberculosis marker] |
| Q77616341 | [False negative and false positive results of tumor markers: their limitation in clinical practice. Clinical applications of CA-125] |